triazolam has been researched along with Cerebrovascular Disorders in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triazolam-treated patients showed subsequent improvement on the tests, consistent with practice effects, whereas flurazepam recipients showed performance impairment during treatment." | 2.67 | Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapy. ( Greenblatt, DJ; Proulx, SM; Woo, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woo, E | 1 |
| Proulx, SM | 1 |
| Greenblatt, DJ | 1 |
1 trial available for triazolam and Cerebrovascular Disorders
| Article | Year |
|---|---|
Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapy.
Topics: Aged; Cerebrovascular Disorders; Double-Blind Method; Evaluation Studies as Topic; Female; Flurazepa | 1991 |